MDT treatment model for diagnosis and treatment of retroperitoneal soft tissue sarcoma in the context of a regional medical center: report of 1 case
10.3760/cma.j.cn115355-20230908-00093
- VernacularTitle:区域医疗中心背景下MDT诊疗模式腹膜后软组织肉瘤诊治1例
- Author:
Xiuping ZHANG
1
;
Fang LI
;
Zhiyong LI
;
Yufu LIN
;
Zhiming WANG
Author Information
1. 复旦大学附属中山医院厦门医院肿瘤内科，厦门 361015
- Keywords:
Retroperitoneal tumor;
Sarcoma;
Treatment outcome;
Regional medical center;
Multidisciplinary team
- From:
Cancer Research and Clinic
2024;36(6):435-440
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical value of multidisciplinary team (MDT) treatment model for retroperitoneal soft tissue sarcoma (RPS) in the context of a regional medical center.Methods:The diagnosis and treatment of a patient with RPS in MDT model who were admitted to Xiamen Branch, Zhongshan Hospital, Fudan University in October 2020 were summarized, and the literature was reviewed.Results:The patient was a 59-year-old male, he was diagnosed with retroperitoneal INI-1-deficient poorly differentiated sarcoma with multiple systemic metastases. After several rounds of MDT discussions in Shanghai headquarter and Xiamen Branch of Zhongshan Hospital, Fudan University, the patient received systemic antitumor therapy combined with local therapy. After active treatment, the patient obtained a good curative effect. During the follow-up period, the liver and lung lesions slowly enlarged, and the treatment plan was adjusted. The patient had survived for more than 3 years.Conclusions:The diagnosis and treatment of RPS is complex, and the MDT model in the context of a regional medical center can help to formulate the optimal treatment plan for patients and may maximize the survival benefit of patients.
